Open Access
Subscription Access
Open Access
Subscription Access
Double-Blind Clinical Trial of a New Antihistamine Tavegyl (HS-592)
Subscribe/Renew Journal
Abstract not Given.
Keywords
No Keywords given
Subscription
Login to verify subscription
User
Font Size
Information
Abstract Views: 235
PDF Views: 0